Clinical Trial Update: Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 study of Aramchol in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Aramchol

Snippet

Sponsor: Galmed Medical Reserch | Conditions: Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED